Profit & Loss

  • Company Name :
Suven Life Sciences Ltd Industry : (Healthcare)
  • BSE Code:
  • 530239
  • NSE Symbol:
  • SUVEN
  • P/E(TTM):
  • -
  • ISIN Demat:
  • INE495B01038
  • Div & Yield%:
  • -
  • EPS(TTM):
  • -
  • Book Value(₹):
  • 37.90
  • Market Cap(₹Cr.):
  • 2,874.21
  • Face Value(₹):
  • 1.00
Particulars Mar '24 Mar '23 Mar '22 Mar '21 Mar '20
INCOME :          
Sales Turnover 11.69 13.54 11.84 13.48 14.41
Excise Duty - - - - -
Net Sales 11.69 13.54 11.84 13.48 14.41
Other Income 28.59 14.45 5.32 7.75 14.04
Stock Adjustments - - - - -
Total Income 40.28 27.99 17.16 21.23 28.45
EXPENDITURE :          
Raw Materials - - - - -
Power and Fuel Cost 0.26 - - - 1.63
Other Manufacturing Expenses 1.54 0.93 2.59 0.14 0.02
Selling and Administration Expenses 23.06 22.95 27.01 27.61 30.26
Miscellaneous Expenses 1.15 1.52 1.30 0.89 3.17
Employee Benefit Expenses 16.53 15.77 17.46 15.29 14.60
Less: Preoperative Expenditure - - - - -
Total Expenses - - - - -
Operating Profit -2.27 -13.18 -31.22 -22.70 -21.23
Interest 0.24 0.40 0.64 0.91 0.54
Gross Profit -2.51 -13.58 -31.86 -23.61 -21.77
Depreciation 6.50 6.54 4.39 4.35 4.17
Profit Before Tax -9.01 -20.12 -36.25 -27.96 -25.94
Current Tax -1.00 - - 0.38 2.28
Fringe Benefit tax - - - - -
Deferred Tax - - - -5.70 -14.46
Reported Net Profit -8.01 -20.13 -36.25 -22.63 -13.75
Extraordinary Items 12.01 7.79 3.99 0.06 0.50
Adjusted Net Profit -20.02 -27.92 -40.24 -22.69 -14.25
Adjustment below Net Profit -0.06 0.19 -0.15 -0.31 -0.30
Profit/Loss Balance carried down 141.49 161.43 197.83 220.77 234.82
Statutory Appropriations - - - - -
Appropriations - - - - -
P & L Balance carried down 133.43 141.49 161.43 197.83 220.77
Dividend - - - - -
Preference Dividend - - - - -
Equity Dividend (%) - - - - -
Dividend Per Share(Rs) - - - - -
Earnings Per Share-Unit Curr -0.37 -0.92 -2.49 -1.78 -1.08
Earnings Per Share(Adj)-Unit Curr -0.37 -0.92 -2.29 -1.64 -1.00
Book Value 38.77 39.14 32.74 28.66 30.46
Book Value(Adj)-Unit Curr 38.77 39.14 30.17 26.41 28.07